Margaret Clagett-Dame

Corporate Officer/Principal bei University of Wisconsin

Consumer Services

Commercial Services

Profil

Margaret Clagett-Dame was the founder of Deltanoid Pharmaceuticals, Inc. which was founded in 1999, where she held the title of Director & Executive Vice President.
Currently, she is a Professor at the University of Wisconsin since 1989.
Dr. Clagett-Dame has a graduate degree from The Pennsylvania State University and a doctorate degree from the University of Wisconsin.

Aktive Positionen von Margaret Clagett-Dame

Unternehmen	Position	Beginn
University of Wisconsin	Corporate Officer/Principal	01.01.1989

Alle aktiven Positionen von Margaret Clagett-Dame

Ehemalige bekannte Positionen von Margaret Clagett-Dame

Unternehmen	Position	Ende
Deltanoid Pharmaceuticals, Inc. Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI.	Gründer	-

Sehen Sie sich die Erfahrung von Margaret Clagett-Dame im Detail an

Ausbildung von Margaret Clagett-Dame

University of Wisconsin	Doctorate Degree
The Pennsylvania State University	Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Margaret Clagett-Dame im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Deltanoid Pharmaceuticals, Inc. Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI.	Commercial Services